Current Heart Failure Reports

, Volume 9, Issue 4, pp 319–327

Anemia and Iron Deficiency in Heart Failure

Pathophysiology of Myocardial Failure (IS Anand, Section Editor)

DOI: 10.1007/s11897-012-0112-x

Cite this article as:
Gunawardena, S. & Dunlap, M.E. Curr Heart Fail Rep (2012) 9: 319. doi:10.1007/s11897-012-0112-x

Abstract

Anemia is a common comorbidity in heart failure (HF), and is associated with increased morbidity and mortality. However, it remains unclear whether anemia is merely a marker of poor prognosis or whether anemia itself confers risk. The pathogenesis of anemia in HF is multifactorial. Iron deficiency also confers risk in HF, either with or without associated anemia, and treatment of iron deficiency improves the functional status of patients with HF. An ongoing large clinical trial studying the use of darbepoetin–alfa in patients with anemia and systolic HF is expected to provide information that should improve our understanding of anemia in HF.

Keywords

Heart failureAnemiaIron deficiencyErythropoietin stimulating agentsIntravenous iron

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.MetroHealth Campus of Case Western Reserve UniversityClevelandUSA